Business · 29/08/2019Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Placebos and Blinding in Cancer Clinical Trials for Drug and Biological Products
The FDA has released a final guidance for the pharmaceutical industry on the use of placebos and blinding in cancer clinical trials for drug and biological products, finalizing recommendations made in 2018.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →